Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Net Cash Flow Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 121.80%
Jun 30, 2025 87.18%
Mar 31, 2025 37.28%
Dec 31, 2024 73.96%
Sep 30, 2024 -63.55%
Jun 30, 2024 190.02%
Mar 31, 2024 91.72%
Dec 31, 2023 -199.97%
Sep 30, 2023 475.93%
Jun 30, 2023 -675.81%
Mar 31, 2023 -966.17%
Dec 31, 2022 1,379.30%
Sep 30, 2022 139.52%
Jun 30, 2022 -106.58%
Mar 31, 2022 -108.69%
Dec 31, 2021 43.25%
Sep 30, 2021 -588.13%
Jun 30, 2021 956.36%
Mar 31, 2021 915.92%
Dec 31, 2020 21.88%
Sep 30, 2020 82.28%
Jun 30, 2020 -199.55%
Mar 31, 2020 -766.00%
Dec 31, 2019 -129.54%
Sep 30, 2019 -59.29%
Jun 30, 2019 279.67%
Mar 31, 2019 -90.95%
Dec 31, 2018 120.20%
Sep 30, 2018 -343.81%
Jun 30, 2018 85.04%
Mar 31, 2018 3,743.96%
Dec 31, 2017 -32.72%
Sep 30, 2017 149.95%
Jun 30, 2017 66.46%
Mar 31, 2017 94.65%
Dec 31, 2016 175.73%
Sep 30, 2016 -113.74%
Jun 30, 2016 -180.61%
Mar 31, 2016 -8.35%
Dec 31, 2015 37.84%
Sep 30, 2015 48.50%
Jun 30, 2015 50.91%
Mar 31, 2015 -191.08%
Dec 31, 2014 -535.23%
Sep 30, 2014 333.38%
Jun 30, 2014 -158.97%
Mar 31, 2014 161.36%
Dec 31, 2013 89.40%
Sep 30, 2013 -122.94%
Jun 30, 2013 2,110.41%
Mar 31, 2013 -558.27%
Dec 31, 2012 -246.94%
Sep 30, 2012 1,695.54%
Jun 30, 2012 -114.61%
Mar 31, 2012 1,177.89%
Dec 31, 2011 -335.24%
Sep 30, 2011 116.13%